Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

• 主要な著者: Lisa Sanderson (著者), Marcelo da Silva (著者), Gayathri N Sekhar (著者), Rachel C Brown (著者), Hollie Burrell-Saward (著者), Mehmet Fidanboylu (著者), Bo Liu (著者), Lea Ann Dailey (著者), Cécile A Dreiss (著者), Chris Lorenz (著者), Mark Christie (著者), Shanta J Persaud (著者), Vanessa Yardley (著者), Simon L Croft (著者), Margarita Valero (著者), Sarah A Thomas (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2021-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

<h4>Background</h4>Human African trypanosomiasis (HAT or sleeping sickness) is caused by the parasite Trypanosoma brucei sspp. The disease has two stages, a haemolymphatic stage after the bite of an infected tsetse fly, followed by a central nervous system stage where the parasite penetr...